Feature | Cardiac Imaging | July 24, 2019 | Greg Freiherr

FFR-CT: Is It Radiology or Cardiology?

AHRA speakers say chest pain patient benefit is more important question 

An example of FFR-CT imaging from Beaumont Hospital in Royal Oak, Mich. The left image shows a 3D generated image of the coronary tree from a CT scan evaluated with computational fluid dynamics to determine the FFR numbers. It shows a severe restriction of the left main artery which requires a stent to revacularize. The image on the right is a comparison with the invasive angiogram from the cath lab prior to stenting.

An example of FFR-CT imaging from Beaumont Hospital in Royal Oak, Mich. The left image shows a 3D generated image of the coronary tree from a CT scan evaluated with computational fluid dynamics to determine the FFR numbers. It shows a severe restriction of the left main artery which requires a stent to revacularize. The image on the right is a comparison with the invasive angiogram from the cath lab prior to stenting. 

Ali Westervelt presents information at AHRA 2019 supporting the value of FFR-CT as a noninvasive cardiac test for patients at moderate risk of coronary artery disease. Her co-presenter, Curt Bush, looks on. Photo by Greg Freiherr

Ali Westervelt presents information at AHRA 2019 supporting the value of FFR-CT as a noninvasive cardiac test for patients at moderate risk of coronary artery disease. Her co-presenter, Curt Bush, looks on. Photo by Greg Freiherr

This example of a coronary CT exams on the left shows what looks like severe coronary blockages due to calcified plaques. However, the FFR-CT image of the right  shows the FFR analisys and no stent is needed.  Imaging courtesy of Beaumont Hospital in Royal Oak, Mich.

This example of a coronary CT exams on the left shows what looks like severe coronary blockages due to calcified plaques. However, the FFR-CT image of the right  shows the FFR analysis and no stent is needed.  Imaging courtesy of Beaumont Hospital in Royal Oak, Mich.

One of the big trends in cardiac computed tomography (CT) imaging has been the introduction of noninvasive fractional flow reserve CT (FFR-CT), which can be used instead of a catheter-based FFR in the cath lab. FFR-CT is being claimed by both cardiology and radiology. The critically important question, however, transcends turf issues. Will patients suspected of having coronary artery disease benefit from its use?

Evidence presented July 22 during an Association for Medical Imaging Management (AHRA) 2019 meeting session entitled “Functional Flow Reserve CT: A New Frontier for Cross Collaboration,” indicates that FFR-CT can substantially benefit patients suspected of heart disease.

During the AHRA presentation, Ali Westervelt cited a study published in the Journal of the American College of Cardiology indicating that questions about obstructive coronary artery disease (CAD) in six of 10 patients who might otherwise be sent for cardiac catheterization could be answered with FFRct.  During the presentation, Westervelt described a slide indicating that FFR-CT can dramatically reduce the need for cardiac catheterization.  Its use, she said, focuses  attention on patients most likely to test positively for CAD, as three of four patients sent to cardiac cath are found to have coronary artery disease.
 
The slide was based on research presented in the paper “1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease." Westervelt and her colleague in the presentation, Curt Bush, noted that at one-year follow-up, no cardiac events were seen in 117 patients who had cardiac cath cancelled based on FFR-CT results.  Additionally, mean costs were 33 percent lower with FFRct versus  the usual care strategy — $8,127 compared with $12,145, respectively. The authors of the paper concluded that “selective FFR-CT was associated with equivalent clinical outcomes, quality of life, and lower costs, compared with usual care over one-year follow-up.”
 
 
Value of FFR-CT in Evaluating Coronary Artery Disease
 
Co-speaker Bush, director of diagnostic and therapeutic imaging services at Baylor St. Luke's Medical Center in Houston, Texas, summarized the value of FFR-CT, telling Imaging Technology News that the noninvasive  procedure  can be “the right thing for the patient.” 
 
FFR-CT has been proven to reduce unnecessary hospital admissions, according to Bush and Westervelt.  In their presentation, they cited research showing that FFRct provides the information that cardiologists need without the expense, time or patient inconvenience of tests done in the nuclear medicine or cardiac catheterization labs.  
 
Despite the advantages of FFR-CT, however, only about 200 facilities in the United States perform this procedure, according to Westervelt, who speculated that the young age of the procedure and its reimbursement status may have been barriers to wider adoption. “It is only about a three-year-old technology and until recently was not reimbursable,” she said. 
 
The Centers for Medicare and Medicaid Services (CMS) began paying for FFR-CT January 2018.  “I think there was just not a lot of interest because everybody is looking at their business plan,” said Westervelt, who is transitioning to a new job in which she expects to perform FFR-CT.
 
 
After the presentation, members of the audience raised questions about the potential loss of revenue that might occur because FFR-CT could cut into the number of cath procedures. Bush and Westervelt responded that the top consideration should be the potential benefit to patients.
 
Because the procedure involves radiology and cardiology, both service lines could become more integrated, the two speakers agreed. This is beginning to happen, Bush said: “There are more and more imaging directors that are including cardiology — both noninvasive and invasive (procedures) — in their scope of practice.”
 
Increased cross collaboration by the often rivalrous specialties was the main point of the presentation, according to Bush, who said: “Imaging services are imaging services whether they come from the radiology or cardiology side.”    
 
 
FFR-CT is Not for All Patients
 
Early in the presentation, Westervelt noted that FFR-CT is restricted to patients at moderate risk of heart disease. These are patients who exhibit stable angina, but have significant risk factors. Those at severe risk still need to be assessed using cardiac cath, the two speakers agreed.
 
Also there are equipment requirements. Among them are the need for a state-of-the-art CT scanner with a 64-slice minimum per rotation and a one-beat imaging detector measuring 8 cm. FFR-CT candidates are only patients who do not have a bypass graft, fistulas larger than 1.5 mm, or metallic stents in certain coronary arteries. If they do, HeartFlow, the company that post-processes flow fractional reserve CT images, will not be able to process their images, according to the presentation.
 
The speakers contended that for facilities with adequate equipment and patients who meet the requirements, FFR-CT can promote better utilization of imaging assets and more efficient use of cardiac catheterization. Use of the procedure can lead to an overall reduction of indirect and direct costs of care and improved fiscal return on assets, they said. To achieve these positive effects, however, FFR-CT must not impact the facility’s CT operation, they said. 
 
These considerations brought the discussion full circle to whether FFRct should be part of cardiology or radiology. The question is rendered moot, they said, if radiology and cardiology can unify the speakers said.
 
In the case of FFR-CT, this might be achieved simply by looking at the procedure as a form of “imaging” — essentially an element of a unified service line composed of both radiology and cardiology. 
 
At the end of the session, Bush asked rhetorically: “Are we at a point now where we are all (about) imaging?” 
 
 
Additional FFR-CT Content:
 

Greg Freiherr is a contributing editor to Imaging Technology News. Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Editor’s note: This article is the fifth piece in a content series by Greg Freiherr covering the Association for Medical Imaging Management (AHRA) annual meeting in Denver. The first article, How Standardizing Protocols Can Save Time and Money, can be found here. The second article, How Artificial Intelligence Might Impact Radiology, can be found here. The third article, How To Manage Risk in the MR Suite, can be found here. The fourth article, DR Advances Promote Imaging of Whole Spine, can be found here.

 

Related AHRA and Radiology Management Content:

Payment Models Seek Traction in Transition from Volume

DR Advances Promote Imaging of Whole Spine 

How Standardizing Protocols Can Save Time and Money

How Artificial Intelligence Might Impact Radiology

How To Manage Risk in the MR Suite

CMS Proposes New Alternative Payment Model for Radiation Oncology 

Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging 

Growth Of ACOs And Alternative Payment Models In 2017 

Related Content

In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19) #COVID19 #COVID-2019 #2019nCoV #COVID-19

Chest CT images of a 29-year-old man with fever for 6 days. RT-PCR assay for the SARS-CoV-2 using a swab sample was performed on Feb. 5, 2020, with a positive result. (A column) Normal chest CT with axial and coronal planes was obtained at the onset. (B column) Chest CT with axial and coronal planes shows minimal ground-glass opacities in the bilateral lower lung lobes (yellow arrows). (C column) Chest CT with axial and coronal planes shows increased ground-glass opacities (yellow arrowheads). (D column) Chest CT with axial and coronal planes shows the progression of pneumonia with mixed ground-glass opacities and linear opacities in the subpleural area. (E column) Chest CT with axial and coronal planes shows the absorption of both ground-glass opacities and organizing pneumonia. Image courtesy of Radiology

News | Computed Tomography (CT) | February 26, 2020 | Melinda Taschetta-Millane and Dave Fornell
February 26, 2020 — In a study of m
 over the course of a week and a half #coronavirus #COVID19 #COVID-2019 #2019nCoV

29-year old male with unknown exposure history, presenting with fever and cough, ultimately requiring intensive care unit admission. (a) Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass (solid arrows) and consolidative (dashed arrows) pulmonary opacities. (b) The disease in the right middle and lower lobes has a striking peripheral distribution (arrow). Image courtesy of Radiology 

News | Computed Tomography (CT) | February 26, 2020
February 26, 2020 — Mount Sinai Health System physicians—the
Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV) #coronavirus #nCoV2019 #2019nCoV #COVID19

Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV). Three representative axial thin-section chest CT images show multifocal ground glass opacities without consolidation. Three-dimensional volume-rendered reconstruction shows the distribution of the ground-glass opacities (arrows). Image courtesy of the Radiological Society of North America (RSNA)

News | Radiology Imaging | February 25, 2020
February 24, 2020 — The U.S.
Carestream’s state-of-the-art OnSight 3D Extremity System
News | Computed Tomography (CT) | February 25, 2020
February 25, 2020 — Carestream’s state-of-the-art...
An axial CT image obtained without intravenous contrast in a 36‐year‐old male (Panel A) shows bilateral ground‐glass opacities in the upper lobes with a rounded morphology (arrows). #coronavirus #nCoV2019 #2019nCoV #COVID19

An axial CT image obtained without intravenous contrast in a 36‐year‐old male (Panel A) shows bilateral ground‐glass opacities in the upper lobes with a rounded morphology (arrows). Image courtesy of Radiology Online.

News | Computed Tomography (CT) | February 20, 2020
February 20, 2020 — In new research
Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020
February 19, 2020 — In new research
Novel Coronavirus 2019-nCoV Pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Image by _freakwave_ from Pixabay 

News | Computed Tomography (CT) | February 16, 2020
February 16, 2020 — The following statement was issued by the U.S.
negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Figure 1: Patient flowchart. Of 167 patients screened, 5 (3%) had negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. Chart courtesy of Radiology

Feature | Computed Tomography (CT) | February 14, 2020 | By Melinda Taschetta-Millane
As the 2019-nCoV Pneumonia is taking the world by storm, researchers have found a possible way to predict this virus
The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.